Eukaryotic Translation Elongation Factor 2 (EEF2)

Eukaryotic Translation Elongation Factor 2 (EEF2)

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">Eukaryotic Translation Elongation Factor 2 (EEF2)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>EEF2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Eukaryotic Translation Elongation Factor 2 (EEF2)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=EEF2" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">103 edges</a></td>
</tr>
</table>

Eukaryotic Translation Elongation Factor 2 (EEF2)

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">Eukaryotic Translation Elongation Factor 2 (EEF2)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>EEF2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Eukaryotic Translation Elongation Factor 2 (EEF2)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=EEF2" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">103 edges</a></td>
</tr>
</table>

Eukaryotic Translation Elongation Factor 2 (EEF2) is a GTP-dependent molecular motor that catalyzes the translocation step of protein synthesis, moving the peptidyl-tRNA from the A-site to the P-site of the ribosome with each elongation cycle.[@kenney2024] As one of the most essential translation factors, EEF2 ensures the faithful progression of protein synthesis beyond initiation, making it indispensable for cellular function. Beyond its canonical role in translation, EEF2 has emerged as a critical regulator of synaptic plasticity, memory formation, and cellular stress response, positioning it at the intersection of neuronal function and dysfunction.

The dysregulation of EEF2 has been increasingly implicated in major neurodegenerative diseases, particularly [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease).[@johnson2019] Altered EEF2 phosphorylation, expression, and function have been documented in post-mortem brain tissue from patients with these conditions, as well as in cellular and animal models. The vulnerability of EEF2 in neurodegeneration likely reflects both the high translational demands of neurons and the importance of precise translation control for synaptic plasticity and proteostasis. This page provides a comprehensive overview of EEF2's structure, molecular mechanisms, cellular functions, and disease associations.

Pathway / Interaction Diagram

Molecular Mechanism of Translocation

The Translocation Reaction

EEF2 is the eukaryotic homolog of bacterial elongation factor G (EF-G), and like its bacterial counterpart, it functions as a GTP-dependent translocase that catalyzes one of the most mechanically demanding steps in the translation elongation cycle.[@gromadski2007] Following peptide bond formation, the peptidyl-tRNA resides in the A-site while the deacylated tRNA occupies the P-site. EEF2•GTP binding to the ribosome triggers a series of conformational changes that first move the peptidyl-tRNA to the P-site and then the deacylated tRNA to the E-site, completing the translocation reaction.

The translocation reaction involves a complex series of movements including ratchet-like rotations of the small ribosomal subunit relative to the large subunit, as well as movements of the tRNAs and the messenger RNA. EEF2 participates in these movements through a "power stroke" mechanism driven by GTP hydrolysis, although the precise mechanical details continue to be refined through structural and kinetic studies.

GTP Hydrolysis and Factor Recycling

The GTPase activity of EEF2 is activated upon ribosome binding, and GTP hydrolysis provides the energy for translocation. Following translocation, EEF2•GDP is released from the ribosome and must be recycled to its active GTP-bound form through nucleotide exchange, mediated by the nucleotide exchange factor eEF1B (for EEF2) or through spontaneous nucleotide exchange, depending on cellular conditions. The regulation of EEF2's GTPase cycle ensures proper timing of translocation and prevents premature factor release.

The GTPase center of EEF2 contains conserved motifs typical of GTP-binding proteins, including the P-loop (phosphate-binding loop) and Switch I and II regions that undergo conformational changes upon GTP binding and hydrolysis. These structural elements couple GTP hydrolysis to the mechanical movements of translocation, making EEF2 a highly efficient molecular motor.

Structure and Regulation

Protein Domain Architecture

EEF2 is a 725-amino acid protein with a molecular weight of approximately 95 kDa, organized into multiple functional domains. The N-terminal domain contains the GTP-binding region (Domains I and II), which shares structural homology with other GTP-binding proteins. The C-terminal portion of EEF2 includes Domains III, IV, and V, which form a structural complex that interacts with the ribosome and undergoes the large conformational changes required for translocation.

The C-terminal domains of EEF2 contain helical elements that penetrate into the ribosomal A-site and drive the movement of tRNAs during translocation. These domains also interact with the ribosomal proteins that form the channel through which tRNAs and mRNA pass. The overall architecture of EEF2 is optimized for its mechanical function, allowing it to grip the ribosome and catalyze translocation with high efficiency.

Phosphorylation Regulation

EEF2 activity is tightly regulated through phosphorylation, primarily at a specific threonine residue (Threonine 56 in humans). This phosphorylation is catalyzed by calcium/calmodulin-dependent protein kinase (CaMK), specifically CaMKI and CaMKIV, which respond to calcium signals generated by neuronal activity. Phosphorylation at this site dramatically reduces EEF2's ability to catalyze translocation, effectively slowing or halting translation elongation.

The phosphorylation of EEF2 serves as a key regulatory mechanism linking neuronal activity to protein synthesis. During periods of high neuronal activity, calcium influx triggers CaMK activation, leading to EEF2 phosphorylation and translational suppression. This mechanism is particularly important at synapses, where local protein synthesis must be precisely controlled in response to synaptic activity. The dynamic regulation of EEF2 phosphorylation allows neurons to fine-tune protein synthesis according to functional demands.

Dephosphorylation of EEF2 is mediated by protein phosphatase 2A (PP2A) and related phosphatases, restoring EEF2 activity when calcium signals subside. The balance between kinase and phosphatase activities determines the phosphorylation state of EEF2 at any given time, providing a dynamic regulatory system that responds rapidly to changing neuronal conditions.

Role in Synaptic Plasticity

Activity-Dependent Translation Control

Synaptic plasticity, the cellular basis of learning and memory, requires rapid synthesis of new proteins at synapses in response to synaptic activity. EEF2 plays a crucial role in this process by regulating the elongation phase of translation at synapses. The phosphorylation state of EEF2 at synaptic sites is modulated by synaptic activity, creating a direct link between neuronal signaling and local protein synthesis.

During periods of intense synaptic activity, EEF2 phosphorylation increases, suppressing general protein synthesis while paradoxically enhancing the translation of specific synaptic proteins. This differential effect ensures that while overall protein synthesis is reduced, the synthesis of proteins critical for synaptic remodeling continues. The selective translation of specific mRNAs during high neuronal activity is thought to be mediated by changes in translation initiation at these mRNAs, while EEF2 phosphorylation contributes to the overall translational control.

Memory Formation and Consolidation

The role of EEF2 in memory consolidation has been extensively studied in various model systems. Inhibition of EEF2 activity, either through pharmacological means or through manipulation of its phosphorylation state, impairs long-term memory formation in rodents. This reflects the essential nature of protein synthesis during the consolidation phase, when labile synaptic changes are stabilized into long-lasting modifications.

Studies using electrophysiological recordings have demonstrated that EEF2 activity is required for the stabilization of long-term potentiation (LTP), a cellular model of learning. The synthesis of new proteins triggered by synaptic activity is essential for the structural changes that underlie lasting synaptic modifications, and EEF2 is centrally involved in this process.

Dysregulation in Neurological Disorders

Alterations in EEF2 phosphorylation have been implicated in various neurological and psychiatric disorders beyond neurodegenerative diseases. Depression and stress-related disorders are associated with changes in EEF2 phosphorylation in brain regions involved in mood regulation. The mechanism involves dysregulation of calcium signaling and downstream kinase/phosphatase activities that control EEF2's phosphorylation state.

Addiction and reward learning also involve EEF2-dependent translation control, particularly in brain reward circuits. The ability of drugs of abuse to hijack synaptic plasticity mechanisms includes effects on EEF2 signaling, contributing to the long-lasting nature of addiction. Understanding these connections may provide insights into novel therapeutic approaches for these conditions.

Expression in the Nervous System

Brain Region Distribution

EEF2 is expressed throughout the brain, with particularly high levels in regions associated with learning and memory, including the [hippocampus](/brain-regions/hippocampus) and [cerebral cortex](/brain-regions/cortex). Within these regions, EEF2 is enriched in neurons rather than glia, reflecting the high protein synthesis demands of neuronal cells. The protein is distributed throughout neuronal compartments, including cell bodies, dendrites, and dendritic spines, supporting its role in both somatic and synaptic protein synthesis.

In the hippocampus, EEF2 is particularly abundant in the CA1 region and dentate gyrus, areas critical for spatial memory and pattern separation. The expression pattern in these regions aligns with the known functions of EEF2 in memory processes and its vulnerability in Alzheimer's disease, which prominently affects hippocampal circuitry.

Cell Type Specificity

Within the brain, EEF2 is expressed in all neuronal subtypes, including excitatory glutamatergic neurons and inhibitory GABAergic neurons. The protein is also expressed in astrocytes and oligodendrocytes, where it supports the protein synthesis needs of these supporting cells. However, the highest levels of EEF2 and its regulatory kinases are found in neurons, consistent with their specialized roles in activity-dependent protein synthesis.

Neuronal subtypes differ in their utilization of EEF2-dependent translation control, with some populations showing more activity-dependent regulation than others. This variability likely reflects the different plasticity requirements of distinct neuronal types and their involvement in specific neural circuits.

Role in Neurodegenerative Diseases

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), EEF2 dysregulation contributes to the translational deficits that characterize the disease brain. Post-mortem studies have revealed altered EEF2 phosphorylation patterns in Alzheimer's disease tissue, with changes in both the overall phosphorylation state and the specific kinase/phosphatase activities that regulate it. These alterations likely contribute to the well-documented defects in protein synthesis in Alzheimer's disease brain.

The relationship between EEF2 and tau pathology is particularly relevant to Alzheimer's disease pathogenesis. EEF2 has been found in association with neurofibrillary tangles composed of hyperphosphorylated tau, and experimental studies suggest that tau pathology may directly affect EEF2 function. This interaction creates a potential feedforward loop where tau pathology disrupts translation, and translation dysregulation contributes to tau pathology progression.

Amyloid-beta, the aggregating peptide that forms extracellular plaques in Alzheimer's disease, also affects EEF2 function. Exposure of neurons to amyloid-beta leads to altered EEF2 phosphorylation and impaired translation capacity. These effects may contribute to the synaptic dysfunction and loss that are early features of Alzheimer's disease pathogenesis.

The cognitive decline in Alzheimer's disease may reflect, in part, the disruption of EEF2-dependent synaptic plasticity mechanisms. Memory formation and consolidation require precise control of local protein synthesis at synapses, and EEF2 dysfunction impairs these processes. The loss of synaptic proteins and the failure to synthesize new synaptic proteins in response to activity may contribute to the progressive synaptic failure that underlies cognitive decline.

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), EEF2 dysfunction has been documented in both patient tissue and experimental models. The dopaminergic neurons of the substantia nigra, which are particularly vulnerable in Parkinson's disease, show altered EEF2 expression and phosphorylation. This vulnerability may stem from the high translational demands of these neurons and their dependence on precise proteostatic control.

Alpha-synuclein, the protein that forms Lewy bodies in Parkinson's disease brains, interacts with translation machinery including EEF2. These interactions may contribute to the translational dysregulation observed in Parkinson's disease and in cellular models of alpha-synuclein toxicity. The connection between alpha-synuclein aggregation and translation dysfunction suggests a common pathway in neurodegeneration.

Mitochondrial dysfunction is a central feature of Parkinson's disease, and EEF2 plays roles in mitochondrial protein synthesis and cellular energy metabolism. The intersection between EEF2 function and mitochondrial health may be particularly relevant to dopaminergic neuron vulnerability, which is characterized by prominent mitochondrial defects.

Other Neurodegenerative Conditions

EEF2 dysfunction has been implicated in other neurodegenerative conditions, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and various ataxias. In ALS, altered EEF2 phosphorylation contributes to the translational dysregulation observed in motor neurons, potentially accelerating disease progression. The involvement of EEF2 in multiple neurodegenerative conditions reflects its fundamental importance for neuronal homeostasis.

Spinocerebellar ataxias, a group of disorders characterized by progressive cerebellar dysfunction, have been associated with EEF2 mutations in some cases. These genetic findings provide direct evidence for EEF2's importance in neuronal function and demonstrate that dysfunction of this essential translation factor is sufficient to cause neurological disease.

Mechanistic Connections

Integration with Initiation and Termination

EEF2 function is integrated with other phases of translation through various mechanisms. The rate of elongation affects the recycling of ribosomal subunits and the availability of translation factors for new rounds of initiation. When EEF2 activity is reduced, ribosomal stacking can occur, affecting the overall translational capacity of the cell. This integration ensures coordinated regulation of protein synthesis according to cellular conditions.

Quality control mechanisms at the ribosome, including ribosome-associated quality control (RQC), interact with EEF2 to ensure proper translation completion. When translation stalls, specialized pathways resolve the stalled complexes and recycle ribosomal subunits. EEF2 may participate in these quality control processes, adding another layer of regulation to protein synthesis.

Stress Response Pathways

EEF2 is involved in cellular stress response pathways beyond its direct translational functions. Under various stress conditions, including nutrient deprivation, oxidative stress, and endoplasmic reticulum stress, EEF2 phosphorylation increases, reducing translation elongation. This global suppression of protein synthesis conserves cellular resources and facilitates stress adaptation.

The integration of EEF2 with stress response pathways is particularly relevant to neurodegeneration, where chronic cellular stress is a common feature. The ability of stress to modulate EEF2 activity may contribute to the translational dysregulation observed in disease states, creating a potential vicious cycle where stress impairs translation, and impaired translation leads to further proteostatic stress.

Therapeutic Implications

Targeting EEF2 in Neurodegeneration

The involvement of EEF2 dysregulation in multiple neurodegenerative diseases has raised interest in therapeutic targeting of this translation factor. However, the fundamental importance of EEF2 for cellular viability creates challenges for direct targeting, as complete inhibition would be profoundly toxic. Strategies that modulate rather than inhibit EEF2 activity may be more tractable.

Approaches to restore proper EEF2 phosphorylation balance, by targeting the kinases and phosphatases that regulate its phosphorylation state, represent one therapeutic strategy. Similarly, interventions that improve overall translational homeostasis may indirectly benefit EEF2 function. The development of biomarkers to monitor EEF2 function in patients could facilitate the development and testing of such interventions.

Modulation of Synaptic Translation

Given EEF2's central role in activity-dependent synaptic protein synthesis, modulators of EEF2 activity may have applications in enhancing synaptic plasticity in conditions where this is impaired. However, the complexity of EEF2's functions requires careful consideration of potential off-target effects and the precise timing of interventions.

Cross-Links to Related Topics

EEF2 connects to numerous other topics within NeuroWiki:

• [Translation Elongation](/entities/translation-elongation) — The core process that EEF2 catalyzes
• [Translation Factors](/entities/translation-factors) — EEF2 as a key translation factor
• [Synaptic Plasticity](/entities/synaptic-plasticity) — EEF2's role in memory and learning
• [Ribosomal Proteins](/ribosomal-proteins) — The ribosome and EEF2 function together
• [Alzheimer's Disease](/diseases/alzheimers-disease) — EEF2 dysregulation in disease
• [Parkinson's Disease](/diseases/parkinsons-disease) — EEF2 and dopaminergic vulnerability
• [Memory Formation](/entities/memory-formation) — EEF2 in cognitive processes
• [Calcium Signaling](/entities/calcium-signaling) — The signaling pathway that regulates EEF2 phosphorylation

See Also

• [Genes Index](/genes)
• [Translation Factors](/entities/translation-factors)
• [Neuronal Translation Control](/entities/neuronal-translation)
• [Synaptic Function](/entities/synaptic-function)
• [Neurodegeneration Mechanisms](/diseases/neurodegeneration)

External Links

• [EEF2 - GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=EEF2)
• [EEF2 - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/1939)
• [EEF2 - UniProt](https://www.uniprot.org/uniprot/P13641)
• [OMIM Entry 130610](https://www.omim.org/entry/130610)
• [Ensembl: ENSG00000167658](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167658)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving Eukaryotic Translation Elongation Factor 2 (EEF2) discovered through SciDEX knowledge graph analysis: